Adverum Biotechnologies logo

Adverum Biotechnologies jobs and careers

Redwood City. Jobs in Redwood City

Headquartered in Redwood City
3Open roles

About Adverum Biotechnologies

Adverum Biotechnologies, Inc., wholly owned subsidiary of Eli Lilly and Company, is a mission-driven clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies designed to be delivered in physicians’ offices to eliminate the need for frequent ocular injections to treat these diseases. By overcoming the challenges associated with current treatment paradigms for these debilitating ocular...

Founded in 2006 by Mark S. Blumenkranz, Steven D. Schwartz, Thomas W. Chalberg and PhD.

Founded
2006
Employees
101 to 250
Total funding
$814.9M
Headquarters
Redwood City
Hiring in
1 city

Leadership

The top of Adverum Biotechnologies's org chart, with how many people report into each leader.

LFPhoto of Laurent Fischer

Laurent Fischer

President & CEO

117 reports

KSPhoto of Kishor Peter Soparkar

Kishor Peter Soparkar

COO

21 reports

RRPhoto of R. Andrew Ramelmeier

R. Andrew Ramelmeier

Chief Technology Officer

7 reports

RCPhoto of Romuald Corbau

Romuald Corbau

Chief Scientific Officer

15 reports

DHPhoto of Dena House

Dena House

SVP, Human Resources, Organizational Development & Learning

4 reports

BTPhoto of Bill Tan

Bill Tan

SVP & Head, Global Clinical Operations

18 reports

AFPhoto of Aneta Ferguson

Aneta Ferguson

Svp, General Counsel

2 reports

AR

Andy Ramelmeier

Chief Technology Officer

PSPhoto of Peter Soparkar

Peter Soparkar

Chief Operating Officer

21 reports

Board

JS

James Scopa

Director

DSPhoto of Dawn Svoronos

Dawn Svoronos

Director

ROPhoto of Rabia Gurses Ozden

Rabia Gurses Ozden

Director

JHPhoto of Jeffrey Heier

Jeffrey Heier

Scientific Advisor

CN

C. David Nicholson

Director